Rhenman & Partners Asset Management AB Has $261,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Rhenman & Partners Asset Management AB decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 99.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 500 shares of the healthcare conglomerate’s stock after selling 59,500 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in UnitedHealth Group were worth $261,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Keebeck Wealth Management LLC raised its position in shares of UnitedHealth Group by 11.6% in the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after buying an additional 1,122 shares in the last quarter. D.A. Davidson & CO. raised its position in shares of UnitedHealth Group by 24.0% in the 2nd quarter. D.A. Davidson & CO. now owns 42,045 shares of the healthcare conglomerate’s stock valued at $20,209,000 after buying an additional 8,144 shares in the last quarter. Ascension Capital Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $216,000. Blue Chip Partners LLC grew its holdings in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Blue Chip Partners LLC now owns 49,995 shares of the healthcare conglomerate’s stock valued at $24,030,000 after purchasing an additional 228 shares during the last quarter. Finally, Physician Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $207,000. Institutional investors and hedge funds own 85.69% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on UNH. HSBC reaffirmed a “reduce” rating and set a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a research report on Monday, October 23rd. Royal Bank of Canada restated an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Tuesday, January 16th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. Finally, StockNews.com cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 21st. One investment analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $575.79.

View Our Latest Stock Analysis on UnitedHealth Group

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $2.98 during mid-day trading on Monday, hitting $515.24. 1,094,729 shares of the company traded hands, compared to its average volume of 4,229,879. The stock has a market cap of $476.56 billion, a price-to-earnings ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The stock has a fifty day moving average price of $525.36 and a 200-day moving average price of $517.84.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same period in the prior year, the business posted $5.34 EPS. The firm’s revenue was up 14.1% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current fiscal year.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.